Penn Davis Mcfarland Inc. Increases Stock Holdings in UnitedHealth Group Incorporated $UNH

Key Points

• Penn Davis Mcfarland Inc. significantly increased its holdings in UnitedHealth Group by 90.3% during the second quarter, owning 134,504 shares valued at approximately $41.96 million.
• UnitedHealth Group reported $4.08 EPS in its latest quarterly earnings, missing analysts' expectations, while its revenue reached $111.62 billion, just below estimates.
• The company announced a quarterly dividend of $2.21 per share, reflecting an annualized dividend yield of 2.5% and a payout ratio of 38.30%.

Penn Davis Mcfarland Inc. increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 90.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 134,504 shares of the healthcare conglomerate's stock after acquiring an additional 63,819 shares during the quarter. UnitedHealth Group comprises 4.7% of Penn Davis Mcfarland Inc.'s portfolio, making the stock its 5th biggest holding. Penn Davis Mcfarland Inc.'s holdings in UnitedHealth Group were worth $41,961,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the business. Brighton Jones LLC increased its stake in shares of UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after purchasing an additional 28,231 shares during the period. Revolve Wealth Partners LLC boosted its stake in shares of UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after buying an additional 2,324 shares during the period. Probity Advisors Inc. boosted its stake in shares of UnitedHealth Group by 45.2% in the fourth quarter. Probity Advisors Inc. now owns 848 shares of the healthcare conglomerate's stock valued at $429,000 after buying an additional 264 shares during the period. Wood Tarver Financial Group LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $73,000. Finally, Copia Wealth Management bought a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $42,000. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Price Performance

UNH stock opened at $351.87 on Thursday. The company has a fifty day moving average price of $298.81 and a 200-day moving average price of $362.32. The company has a market capitalization of $318.68 billion, a P/E ratio of 15.25, a PEG ratio of 2.27 and a beta of 0.45. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business's revenue was up 12.9% compared to the same quarter last year. During the same quarter last year, the business posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group's payout ratio is presently 38.30%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the company. KeyCorp cut their price target on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating for the company in a research note on Wednesday, July 30th. Bank of America upped their target price on UnitedHealth Group from $290.00 to $325.00 and gave the stock a "neutral" rating in a research note on Monday, August 18th. Barclays upped their target price on UnitedHealth Group from $337.00 to $352.00 and gave the stock an "overweight" rating in a research note on Thursday, September 4th. Truist Financial upped their target price on UnitedHealth Group from $310.00 to $365.00 and gave the stock a "buy" rating in a research note on Tuesday, September 9th. Finally, UBS Group restated a "buy" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Sixteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company. According to MarketBeat.com, UnitedHealth Group currently has an average rating of "Moderate Buy" and an average price target of $358.95.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.